Association of side effects to medication adherence of antiepileptic drug use in epileptic patients

Penulis

  • Iin Ernawati Department of Clinical Pharmacy, Akademi Farmasi Surabaya, Surabaya, 60231, Indonesia ,
  • Oktaviani Putri Wyono Diploma III in Pharmacy, Akademi Farmasi Surabaya, Surabaya, 60231, Indonesia ,
  • Fitria Dewi Yunitasari Department of Clinical Pharmacy, Akademi Farmasi Surabaya, Surabaya, 60231, Indonesia ,
  • Erwindy Yastika Pradani Department of Neurology, Faculty of Medicine, Airlangga Hospital University, Surabaya, 60231, Indonesia ,
  • Wardah Rahmatul Islamiyah Department of Neurology, Faculty of Medicine, Airlangga Hospital University, Surabaya, 60231, Indonesia ,

DOI:

https://doi.org/10.35814/jifi.v22i1.1269

Kata Kunci:

antiepileptic drug, side effect, adherence

Abstrak

Epilepsy is a chronic neurological disorder with symptoms characterized by seizures, arising spontaneously with brief episodes with the main symptom of decreased or loss of consciousness. This study aims to examine the effect of side effects of medication adherence to antiepileptic drug use in epilepsy patients. This research is an observational study that was analyzed using quantitative descriptive methods in Neurology patients at the Airlangga University Hospital from March until May 2022. Side effects were measured using the LAEP (Liverpool Adverse Effects Profile) questionnaire and adherence was measured using a pill count. Results showed that the influence of side effects on medication adherence (pill count method) to antiepileptic drugs using linear regression, it is known that the P-value is 0.501. There is no significant relationship between the category of side effects and medication adherence to antiepileptic drugs. Another factor that influences compliance with medication use is the appearance of seizures. Based on the results of this study, it is known that the greater the frequency of seizures, the more likely patients are to be non-compliant (P-value 0.006). To increase adherence, it is necessary to pay attention to other factors such as knowledge, economy, and type of therapy in epilepsy patients so that therapeutic outcomes can be achieved.

Referensi

Unduhan

Diterbitkan

2024-04-30

Terbitan

Vol 22 No 1 (2024): JIFI

Bagian

Articles

Lisensi

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.